SANA

Sana Biotechnology, Inc.

—

Insider Sentiment

Last purchase: 2024-02-08
Last sale: 2025-01-08
Shares purchased (TTM): 5,454,543
Shares sold (TTM): 465,912

Buy ratio (TTM)92.1%

Institutional Sentiment

As of: 2026-06-30
Institutional shares owned: 185,394,164
Shares outstanding: 295,667,000
Ownership: 62.70%

+3.26% Y/Y

Earnings Market Reaction

Filing date: 2026-08-10
Price on filing date: —
1-month reaction: 6.65%
3-month reaction: …

Drift continued6/11 (55%)

Faded / reversed5/11 (45%)

Export data

Recent filings

10-Q2026-06-30Filed 2026-08-10
10-Q2026-03-31Filed 2026-05-11
10-K2025-12-31Filed 2026-03-03
10-Q2025-09-30Filed 2025-11-06
10-Q2025-06-30Filed 2025-08-11
10-Q2025-03-31Filed 2025-05-08
10-K2024-12-31Filed 2025-03-17
10-Q2024-09-30Filed 2024-11-08
10-Q2024-06-30Filed 2024-08-08
10-Q2024-03-31Filed 2024-05-08
10-K2023-12-31Filed 2024-02-29
10-Q2023-09-30Filed 2023-11-08

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

Balance Sheet

Values in millions ($)

Line item	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets Current
Cash And Cash Equivalents At Carrying Value	57	84	72	103	71	96	128	127	135	177	134	168
Marketable Securities Current	103	17	67	50	1	9	25	72	117	134	72	100
Restricted Cash Current	4	4	4	4	4	4	4	4	4	4	4	4
Prepaid Expense And Other Assets Current	6	6	6	5	6	4	4	7	8	6	4	7
Assets Current	171	112	149	162	83	113	161	210	263	321	214	280
Property Plant And Equipment Net	25	26	27	30	33	74	77	83	86	82	71	68
Operating Lease Right Of Use Asset	35	36	38	41	43	55	58	61	63	72	75	77
Intangible Assets Net Excluding Goodwill	59	59	59	59	59	59	59	59	59	59	59	59
Goodwill	141	141	141	141	141	141	141	141	141	141	141	141
Other Assets Noncurrent	1	1	3	3	3	4	5	6	6	7	6	6
Assets	432	374	417	435	362	445	501	559	619	681	565	631
Liabilities Current
Accounts Payable Current	1	2	2	2	2	1	5	3	4	6	4	10
Employee Related Liabilities Current	9	8	13	11	9	9	14	18	16	14	24	24
Accrued Liabilities And Other Liabilities	8	8	9	8	8	10	13	15	21	20	23	19
Operating Lease Liability Current	15	15	15	14	14	13	13	11	10	13	13	13
Business Combination Contingent Consideration Liability Current	91	54	40	-	-	-	0	-	-	-	-	-
Liabilities Current	124	86	79	36	33	33	45	47	51	53	64	67
Operating Lease Liability Noncurrent	59	60	64	68	72	78	82	85	89	93	91	83
Business Combination Contingent Consideration Liability Noncurrent	60	81	84	115	117	111	109	112	112	115	110	103
Other Liabilities Noncurrent	9	10	11	8	8	9	10	7	7	-	-	-
Liabilities	277	254	256	240	239	236	251	267	279	306	278	266
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	2,114	2,015	2,010	1,985	1,871	1,863	1,855	1,848	1,836	1,821	1,626	1,616
Accumulated Other Comprehensive Income Loss Net Of Tax	-0	-0	0	0	0	0	0	0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-1,960	-1,896	-1,849	-1,790	-1,748	-1,654	-1,605	-1,556	-1,496	-1,446	-1,338	-1,250
Stockholders Equity	155	119	161	195	123	209	251	292	340	375	288	366
Liabilities And Stockholders Equity	432	374	417	435	362	445	501	559	619	681	565	631
Preferred Stock Par Or Stated Value Per Share	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preferred Stock Shares Authorized	50	50	50	50	50	50	50	50	50	50	50	50
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Common Stock Shares Authorized	750	750	750	750	750	750	750	750	750	750	750	750
Common Stock Shares Issued	299	270	267	262	231	225	224	223	222	221	198	197
Shares Outstanding	299	270	267	262	231	225	224	223	222	221	198	197

Select a line item above to chart it.

Recent filings

10-Q2026-06-30Filed 2026-08-10
10-Q2026-03-31Filed 2026-05-11
10-K2025-12-31Filed 2026-03-03
10-Q2025-09-30Filed 2025-11-06
10-Q2025-06-30Filed 2025-08-11
10-Q2025-03-31Filed 2025-05-08
10-K2024-12-31Filed 2025-03-17
10-Q2024-09-30Filed 2024-11-08
10-Q2024-06-30Filed 2024-08-08
10-Q2024-03-31Filed 2024-05-08
10-K2023-12-31Filed 2024-02-29
10-Q2023-09-30Filed 2023-11-08

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

Sana Biotechnology, Inc. (SANA) — SEC Financial Statements & Analysis

Sana Biotechnology, Inc. (SANA) is a biological products, (no diagnostic substances) company, incorporated in DE. Sana Biotechnology, Inc. trades on Nasdaq as: SANA. Sana Biotechnology, Inc. (SANA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10. Based on that filing, Sana Biotechnology, Inc. carries a market cap of $1.03B, a P/E ratio of -4.87x, a P/B ratio of 6.68x, an enterprise value of $970.61M, and an EV/EBITDA multiple of -4.60x. On profitability, it posts a Return on Equity (ROE) of -152.87%, a Return on Assets (ROA) of -53.41%, and a Return on Invested Capital (ROIC) of -311.63%. Per share, it reports EPS of $-0.72, diluted EPS of $-0.72, free cash flow per share of $-0.46, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -16.00% year-over-year and EPS growth of -32.27% year-over-year. On the balance sheet, it maintains a current ratio of 1.38x, a quick ratio of 1.33x, working capital of $46.88M, a debt-to-equity ratio of 1.79x, a debt ratio of 0.64, an interest coverage ratio of -50.18x, free cash flow of $-135.06M (TTM), and net debt of $-61.27M. Figures sourced from SEC EDGAR.

Market Cap: $1.03B
P/E TTM: -4.87x
EPS TTM: $-0.72
P/B TTM: 6.68x
ROE TTM: -152.87%
ROA TTM: -53.41%
Debt To Equity: 1.79x
Free Cash Flow TTM: $-135.06M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Sana Biotechnology, Inc. in?

Sana Biotechnology, Inc. (SANA) operates in the Biological Products, (No Diagnostic Substances) industry.

What exchange does SANA trade on?

Sana Biotechnology, Inc. (SANA) trades on the Nasdaq.

Where is Sana Biotechnology, Inc. incorporated?

Sana Biotechnology, Inc. is incorporated in DE.

When was Sana Biotechnology, Inc. (SANA)'s most recent SEC filing?

Sana Biotechnology, Inc. (SANA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10.

What is SANA's market cap?

Sana Biotechnology, Inc. (SANA) has a market capitalization of $1.03B as of 2026-06-30.

What is SANA's EPS (earnings per share)?

Sana Biotechnology, Inc. (SANA)'s trailing twelve month EPS is $-0.72 as of 2026-06-30.

What is SANA's ROE (return on equity)?

Sana Biotechnology, Inc. (SANA)'s trailing twelve month Return on Equity (ROE) is -152.87% as of 2026-06-30.

What is SANA's ROA (return on assets)?

Sana Biotechnology, Inc. (SANA)'s trailing twelve month Return on Assets (ROA) is -53.41% as of 2026-06-30.

What is SANA's ROIC (return on invested capital)?

Sana Biotechnology, Inc. (SANA)'s trailing twelve month Return on Invested Capital (ROIC) is -311.63% as of 2026-06-30.

What is SANA's EV/EBITDA?

Sana Biotechnology, Inc. (SANA)'s trailing twelve month EV/EBITDA is -4.60x as of 2026-06-30.

Wall Street's data.
Main Street's price.

Start 7-day free trial

SANA

Company Information

Insider Sentiment

Institutional Sentiment

Earnings Market Reaction

Recent filings

Recent filings

Sana Biotechnology, Inc. (SANA) — SEC Financial Statements & Analysis

Frequently Asked Questions

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.